SCHEMBL7760077

SCHEMBL7760077

CCSc1c(C)cccc1C#N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.50
AR P10275 2/20 0.42
MAPT P10636 4/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
PKM P14618 1/20 0.39
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 3/20 0.36
HPGD P15428 2/20 0.36
POLB P06746 1/20 0.36
SCN4A P35499 4/20 0.36
LMNA P02545 1/20 0.35
CLK1 P49759 1/20 0.35
MAPK1 P28482 1/20 0.35
GAA P10253 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15389016 0.88 TSHR (0.41) TSHRARMAPTMEN1KMT2A
SCHEMBL27993496 0.80 ALDH1A1 (0.40) TSHRMAPTMEN1KMT2ATDP1
SCHEMBL31287953 0.80 MAOA (0.51) TSHRMAPTMEN1KMT2ANPSR1
SCHEMBL20801750 0.80 SCN4A (0.50) TSHRMAPTNPSR1ALDH1A1HPGD
SCHEMBL8848578 0.79 MAPK1 (0.37) TSHRARMAPTMEN1KMT2A
SCHEMBL6231963 0.79 TSHR (0.56) TSHRARMAPTMEN1KMT2A
SCHEMBL15358060 0.71 PKM (0.37) TSHRARMAPTMEN1KMT2A
SCHEMBL1922926 0.71 TSHR (0.56) TSHRARMAPTMEN1KMT2A
SCHEMBL4599675 0.71 AR (0.50) TSHRARMAPTMEN1KMT2A
SCHEMBL11498088 0.71 TRPA1 (0.46) TSHRMAPTMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8802862-B2 1,2-benzisothiazol-3-one compound production method SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2014-08-12 US disclosed
EP-2687519-A1 1,2-BENZISOTHIAZOL-3-ONE COMPOUND PRODUCTION METHOD Sumitomo Seika Chemicals CO. LTD. (JP) 2014-01-22 EP disclosed
US-20130345433-A1 1,2-BENZISOTHIAZOL-3-ONE COMPOUND PRODUCTION METHOD SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2013-12-26 US disclosed
EP-1081141-A1 Method for producing 1,2-benzisothiazol-3-ones SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2001-03-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130345433-A1 1,2-BENZISOTHIAZOL-3-ONE COMPOUND PRODUCTION METHOD BZW1, BZW2, NAT1 TSHR 2656/4885AR 2782/4885MAPT 1801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.